Sorina Mihaila (@sorina_mihaila) 's Twitter Profile
Sorina Mihaila

@sorina_mihaila

Senior Lecturer in Cardiology, PhD, EACVI HIT Committee Member, President of the Romanian WG of Cardiovascular Imaging #with a personal opinion

ID: 1043435878939598854

calendar_today22-09-2018 09:44:34

290 Tweet

474 Followers

372 Following

Sorina Mihaila (@sorina_mihaila) 's Twitter Profile Photo

Prof. Alexandre Mebazaa on ā€œthe vulnerable periodā€ after discharge for decompensated heart failure - rapid uptitration to full dose of GMDT improves patients outcomes.

Prof. Alexandre Mebazaa on ā€œthe vulnerable periodā€ after discharge for decompensated heart failure - rapid uptitration to full dose of GMDT improves patients outcomes.
Sorina Mihaila (@sorina_mihaila) 's Twitter Profile Photo

First day of Athens Cardiovascular Imaging Congress, with a session on Cardiotoxicity. #Chemotherapy may lead to direct pericardial and myocardial damage, immune-related effects, and metabolic disturbances. Radiotherapy might have a synergistic effect of cardiotoxicity.

First day of Athens Cardiovascular Imaging Congress, with a session on Cardiotoxicity. #Chemotherapy may lead to direct pericardial and myocardial damage, immune-related effects, and metabolic disturbances. Radiotherapy might have a synergistic effect of cardiotoxicity.
Donal (@donalerwan) 's Twitter Profile Photo

Right ventricular free wall strain predicts transthyretin amyloidosis prognosis as well as biomarker-based staging systems academic.oup.com/ehjcimaging/ar… Filiere Cardiogen RĆ©seau amylose cardiaque

Luigi (@lpbadano) 's Twitter Profile Photo

Proud to have contributed to this excellent review about the imaging in TR. We have learned a lot during the last 10 years. RTHahnMD João Cavalcante Denisa Muraru #ACC25 #JACCIMG #3DEcho

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

#ACC25 Day 2, here is the summary of today’s trials (I haven’t included the follow-up extensions of Evolut Low Risk, Triluminate, and FAME 3). Today, I counted at least 2 NEJM, 4 Lancet, 1 Nature, 1 JAMA, 1 Circulation, and 1 JACC. 1. MIGHTy-Heart = In-home paramedic visits for

#ACC25 Day 2, here is the summary of today’s trials (I haven’t included the follow-up extensions of Evolut Low Risk, Triluminate, and FAME 3). Today, I counted at least 2 NEJM, 4 Lancet, 1 Nature, 1 JAMA, 1 Circulation, and 1 JACC.

1. MIGHTy-Heart = In-home paramedic visits for
Bogdan A. Popescu (@bogdan_popescu1) 's Twitter Profile Photo

#VHD Forum, 10-11 Oct 2025, Hotel Crowne Plaza, Bucharest: 'What's new in the 2025 #ESC/EACTS VHD Guidelines?' with the Chair & members of the GL TF and other KOL. Lectures, cases, hands-on echo workshops, abstracts. Fabien Praz Victoria Delgado Nina Ajmone Marsan Cosyns Bernard European Society of Cardiology

#VHD Forum, 10-11 Oct 2025, Hotel Crowne Plaza, Bucharest: 'What's new in the 2025 #ESC/EACTS VHD Guidelines?' with the Chair &amp; members of the GL TF and other KOL. Lectures, cases, hands-on echo workshops, abstracts. <a href="/FabienPraz/">Fabien Praz</a> <a href="/VDelgadoGarcia/">Victoria Delgado</a> <a href="/NAjmoneMarsan/">Nina Ajmone Marsan</a> <a href="/Cosyns/">Cosyns Bernard</a> <a href="/escardio/">European Society of Cardiology</a>
EACVI President (@eacvipresident) 's Twitter Profile Photo

Join Us at the #EACVI 2025 Conference in Vienna! šŸ“… December 11-13, 2025 šŸ“ Vienna, Austria Experience the future of cardiovascular imaging as #EuroEcho #ICNCCT & #EuroCMR come together under one roof at the #EACVI 2025 Conference! šŸ”¹ Cutting-edge research šŸ”¹ Expert-led

Victoria Delgado (@vdelgadogarcia) 's Twitter Profile Photo

For all the passionate professionals for cardiovascular imaging, this is your opportunity to mingle with, to network with and to learn from a large community with expertise on 4 modalities. Take advantage and join us! escardio.org/Congresses-Eve… L'Institut del Cor del Germans Trias Asociación de Imagen Cardiaca SEC

Sam Tsimikas, MD (@lpa_doc) 's Twitter Profile Photo

Now that people are checking Lp(a), it is becoming more obvious and accepted. When we published our paper on this, we had a lot of negative reactions because it was not clear if this was clinically relevant or would make people stop taking statins. Bottom line is statins treat

Now that people are checking Lp(a), it is becoming more obvious and accepted. When we published our paper on this, we had a lot of negative reactions because it was not clear if this was clinically relevant or would make people stop taking statins.  Bottom line is statins treat
Sorina Mihaila (@sorina_mihaila) 's Twitter Profile Photo

šŸ“•Early referral for moderate-to-severe secondary TR is recommended by L. Badano to reduce surgical/interventional risk and improve survival.ā€œSecondary TR should be carefully assessed for the oportunity for interventions/surgery even before needing diuretic. Athens Group Congress

šŸ“•Early referral for moderate-to-severe secondary TR is recommended by L. Badano to reduce surgical/interventional risk and improve survival.ā€œSecondary TR should be carefully assessed for the oportunity for interventions/surgery even before needing diuretic. Athens Group Congress